1-2 of 2
David H. Bevan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

Clinical Trials & Observations
Barbara A. Konkle, Oleksandra Stasyshyn, Pratima Chowdary, David H. Bevan, Tim Mant, Midori Shima, Werner Engl, Jacqueline Dyck-Jones, Monika Fuerlinger, Lisa Patrone, Bruce Ewenstein, Brigitt Abbuehl
Journal: Blood
Blood (2015) 126 (9): 1078–1085.
https://doi.org/10.1182/blood-2015-03-630897
Published: 2015
Includes: Supplemental data
Journal Articles

Long Term Regular Automated Red Cell Exchange Transfusion Significantly Reduces Symptoms and Hospital Admissions in Sickle Cell Anaemia.

Michaela A. Pocock, RGN, MSc, Adriaan van Heerden, MSc, PhD, Modupe O. Elebute, MRCP, MRCPath, MD, Marina Karakantza, MD, David H. Bevan, FRCP, FRCPath
Journal: Blood
Blood (2004) 104 (11): 3746.
https://doi.org/10.1182/blood.V104.11.3746.3746
Published: 2004